Related references
Note: Only part of the references are listed.P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease
Iman Imtiyaz Ahmed Juvale et al.
HELIYON (2022)
Intrathecal diamorphine: a challenger for morphine's 'gold standard' status?
P. Attard Cortis
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA (2020)
The role of 6-acetylmorphine in heroin-induced reward and locomotor sensitization in mice
Anne Marte Sjursen Kvello et al.
ADDICTION BIOLOGY (2020)
Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations
Eloise Baudou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
6-Monoacetylmorphine (6-MAM), Not Morphine, Is Responsible for the Rapid Neural Effects Induced by Intravenous Heroin
David Perekopskiy et al.
ACS CHEMICAL NEUROSCIENCE (2019)
The active heroin metabolite 6-acetylmorphine has robust reinforcing effects as assessed by self-administration in the rat
Riccardo Avvisati et al.
NEUROPHARMACOLOGY (2019)
Human ABC Transporters at blood-CNS Interfaces as Determinants of CNS Drug Penetration
Catarina Chaves et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin
A. Gottas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Pharmacokinetic Correlates of the Effects of a Heroin Vaccine on Heroin Self-Administration in Rats
Michael D. Raleigh et al.
PLOS ONE (2014)
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties
Marianne Seleman et al.
PSYCHOPHARMACOLOGY (2014)
Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice
Fernando Boix et al.
ADDICTION BIOLOGY (2013)
Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats
A. Gottas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Straub tail reaction in mice treated with σ1 receptor antagonist in combination with methamphetamine
Junichi Kitanaka et al.
BRAIN RESEARCH (2012)
Simultaneous measurement of heroin and its metabolites in brain extracellular fluid by microdialysis and ultra performance liquid chromatography tandem mass spectrometry
A. Gottas et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Interplay of Drug Metabolizing CYP450 Enzymes and ABC Transporters in the Blood-Brain Barrier
Xavier Decleves et al.
CURRENT DRUG METABOLISM (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands
Peter Blanken et al.
ADDICTION (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding
Alexis Bailey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Increased Locomotor Activity Induced by Heroin in Mice: Pharmacokinetic Demonstration of Heroin Acting as a Prodrug for the Mediator 6-Monoacetylmorphine in Vivo
Jannike Morch Andersen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain
Derek J. Roberts et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Heroin-assisted treatment (HAT) a decade later: A brief update on science and politics
Benedikt Fischer et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2007)
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Ingolf Cascorbi
PHARMACOLOGY & THERAPEUTICS (2006)
Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters
Supratim Choudhuri et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2006)
Population pharmacokinetics of heroin and its major metabolites
EJ Rook et al.
CLINICAL PHARMACOKINETICS (2006)
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients
EJ Rook et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
B Li et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice
JW Jonker et al.
STEM CELLS (2005)
Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials
W van den Brink et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
μ Opioid receptor-mediated G-protein activation by heroin metabolites:: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine
DE Selley et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Effects of high-dose heroin versus morphine in intravenous drug users: A randomised double-blind crossover study?
RB Haemmig et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2001)
Share Paper
